Reported Reactions

Adverse event reports that FDA received

  • Search
  • Watch list

October 2018 adverse event reports that FDA received in the month

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on . The data have the reports that FDA received through .

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on .

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports received

In October 2018, FDA received 122,768 drug adverse event reports. In October 2017, FDA received 117,287.

In October 2018, FDA received 105,277 medical device reports. In October 2017, FDA received 85,789.

By drug reports received, October 2018 was number 6 of the 12 months of 2018. FDA received 117,270 drug reports a month on average in the 12 months before October 2018.

Receive date

A month is the month in which FDA first received the report, not the month of the event. A report about an event of an earlier year is in the month in which it came to FDA.

Data version

FAERS release of 29 Oct 2026. MAUDE release of 23 Oct 2026.

Drug reports, three years

Drug reports that FDA received each month, 36 months to October 2018
0100,000200,000201620172018

Drugs in the reports

The table has the 120 drug pages with 250 or more reports in October 2018. The rows are in order of name. A drug page with fewer reports is not in the table.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Drugs that the reports of October 2018 name as a suspect product, in order of name
DrugReports in the month
Acetylsalicylic Acid273
Actemra378
Afinitor360
Aimovig3,209
Alprazolam281
Ambrisentan528
Amlodipine350
Apixaban364
Aspirin366
Atorvastatin254
Aubagio380
Avastin263
Avonex456
Capecitabine310
Carboplatin463
Cialis255
Ciprofloxacin261
Codeine290
Copaxone322
Cosentyx2,174
Cyclophosphamide758
Cytarabine315
Dexamethasone799
Diazepam255
Diclofenac382
Docetaxel404
Doxorubicin365
Duodopa251
Dupixent734
Eliquis1,151
Enbrel2,670
Endari348
Entresto1,555
Epclusa255
Esbriet456
Etoposide332
Fentanyl citrate563
Fluorouracil316
Forteo354
Furosemide337
Gabapentin645
Gilenya1,403
Harvoni250
Humalog368
Humira2,747
Ibrance670
Ibuprofen486
Imbruvica436
Insulin glargine343
Jakafi472
Keytruda305
Lamotrigine258
Lantus308
Levetiracetam456
Levofloxacin358
Lisinopril280
Lyrica1,432
Mavyret291
Metformin505
Metformin hydrochloride264
Methotrexate1,436
Methotrexate sodium1,000
Methylprednisolone272
MiraLAX260
Mirena623
Morphine sulfate403
Mycophenolate mofetil440
Neulasta5,032
Nexium386
Nexplanon420
Nivolumab516
Ocrevus347
Olanzapine268
Omeprazole460
Opdivo438
Opsumit436
Orencia593
Otezla1,668
Oxaliplatin380
Oxycodone hydrochloride290
OxyContin315
Paclitaxel379
Pantoprazole334
Paracetamol453
Pomalyst541
Pradaxa399
Praluent409
Prednisolone621
Prednisone956
Prevacid256
Prolia1,033
Quetiapine355
Ramipril287
Remicade576
Remodulin307
Repatha6,092
Revlimid2,154
Risperidone266
Rituximab558
Sertraline287
Simponi448
Soliris656
Stelara706
Sulfasalazine288
Symbicort252
Tacrolimus824
Taltz421
Taxotere571
Tecfidera922
Tramadol323
Tresiba309
Trulicity556
Tysabri622
Vancomycin276
Ventolin Hfa278
Vincristine493
Xarelto993
Xeljanz1,323
Xyrem454
Zytiga372

Reaction terms in the reports

The table has the 130 reaction terms with 500 or more reports in October 2018. The rows are in order of name. One report can record more than one term.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Reaction terms that the drug reports of October 2018 record, in order of name
Reaction term (MedDRA) and plain meaningReports in the month
Abdominal discomfortstomach discomfort999
Abdominal distensiona bloated abdomen571
Abdominal painstomach or belly pain1,285
Abdominal pain upperupper stomach pain1,167
Accidental exposure to product1,846
Acute kidney injurysudden loss of kidney function1,428
Adverse eventan unwanted medical event, type not specified631
Alopeciahair loss1,646
Anaemialow red blood cells996
Anxietyanxiety1,282
Arthralgiajoint pain2,130
Astheniaweakness or lack of energy2,064
Asthmaasthma529
Atrial fibrillationan irregular heart rhythm513
Back painback pain1,629
Blood glucose increasedraised blood sugar reading1,276
Blood pressure increaseda raised blood pressure reading824
Cardiac failureheart failure515
Cerebrovascular accidentstroke762
Chest discomfortchest discomfort563
Chest painchest pain1,027
Chillschills or shivering532
Chronic kidney diseaselong-term kidney disease522
Condition aggravatedthe condition being treated got worse1,588
Confusional stateconfusion861
Constipationconstipation1,326
Contusiona bruise513
Coughcough1,623
Deaththe patient died; cause not stated by this term4,360
Decreased appetitereduced appetite1,237
Dehydrationdehydration607
Depressionlow mood1,095
Diarrhoealoose or frequent stools3,729
Disease progressionthe disease advanced534
Dizzinesslight-headedness or unsteadiness2,805
Drug abusemisuse of a medicine650
Drug dependencedependence on a medicine525
Drug effect decreasedthe medicine had less effect516
Drug effect incomplete757
Drug hypersensitivityan allergic-type reaction (the term names a medicine)2,198
Drug ineffectivethe medicine did not work as expected7,545
Drug interactionan interaction between medicines841
Drug intolerancethe medicine was not tolerated642
Dysphagiadifficulty swallowing504
Dyspnoeashortness of breath3,237
Epistaxisnosebleed502
Erythemaskin redness857
Falla fall1,893
Fatiguetiredness4,531
Feeling abnormalfeeling odd or not right1,529
Gait disturbancedifficulty walking1,116
Gastrointestinal haemorrhagebleeding in the stomach or bowel509
General physical health deteriorationgeneral decline in health540
Haemoglobin decreasedlow haemoglobin602
Headachehead pain3,928
Hospitalisationadmission to hospital889
Hyperhidrosisexcessive sweating815
Hypersensitivityan allergic-type reaction1,092
Hypertensionhigh blood pressure1,065
Hypoaesthesianumbness795
Hypotensionlow blood pressure1,273
Inappropriate schedule of product administrationthe product was taken at the wrong times1,348
Incorrect dose administeredthe wrong dose was given832
Infectionan infection, type not specified834
Influenzaflu600
Influenza like illnessflu-like symptoms666
Injection site bruisingbruising where the injection was given718
Injection site erythemaredness where the injection was given502
Injection site painpain where the injection was given1,719
Insomniadifficulty sleeping1,329
Intentional product misusedeliberate use not as intended757
Intentional product use issuedeliberate use not as intended629
Joint swellinga swollen joint589
Loss of consciousnesspassing out700
Malaisegeneral feeling of being unwell3,175
Malignant neoplasm progression652
Memory impairmentmemory problems839
Migrainemigraine851
Multiple sclerosis relapsea flare of multiple sclerosis573
Muscle spasmsmuscle cramps1,112
Muscular weaknessmuscle weakness605
Myalgiamuscle pain1,124
Myocardial infarctionheart attack525
Nasopharyngitisa cold1,274
Nauseafeeling sick4,260
Neuropathy peripheralnerve damage in hands or feet568
Neutropenialow neutrophils, a type of white blood cell686
No adverse eventno adverse event was reported783
Off label useused for a purpose or in a way not on the label5,402
Oropharyngeal painsore throat601
Overdosea dose above the recommended amount811
Painpain, site not specified3,179
Pain in extremitypain in an arm or leg1,774
Palpitationsawareness of the heartbeat603
Paraesthesiatingling or pins and needles764
Peripheral swellingswelling of the arms or legs1,067
Platelet count decreasedlow platelet count571
Pneumonialung infection1,762
Product dose omissiona dose was missed3,391
Product quality issuea problem with the product itself605
Product storage errorthe product was stored wrongly676
Product use in unapproved indicationused for a purpose not on the label1,909
Product use issuea problem in how the product was used1,190
Pruritusitching1,793
Psoriasispsoriasis, a skin condition875
Pyrexiafever1,897
Rashskin rash2,139
Renal failurekidney failure780
Rheumatoid arthritisrheumatoid arthritis, an inflammatory joint disease526
Rhinorrhoeaa runny nose619
Seizurea fit or convulsion886
Sepsisa severe body-wide response to infection655
Sinusitissinus infection547
Somnolencedrowsiness1,159
Swellingswelling525
Syncopefainting598
Thrombocytopenialow platelets622
Toxicity to various agentspoisoning or toxic effect of one or more substances939
Tremorshaking931
Underdoseless than the intended dose798
Unintentional medical device removal2,005
Urinary tract infectionbladder or urinary infection992
Urticariahives918
Vision blurredblurred vision734
Visual impairmentreduced vision822
Vomitingbeing sick2,411
Weight decreasedweight loss1,466
Weight increasedweight gain1,088
White blood cell count decreasedlow white cell count612
Wrong technique in product usage processthe product was used in the wrong way3,819

Devices in the reports

The table has the 45 device pages with 250 or more reports in October 2018. The rows are in order of name. A device page with fewer reports is not in the table.

FDA says:

MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices.

Source: openFDA, Manufacturer and User Facility Device Experience. The site read the page on .

Device brand names that the device reports of October 2018 name, in order of name
Brand nameReports in the month
530G Insulin Pump MMT-751LNAS266
530g Insulin Pump Mmt-751nas397
630G Insulin PUMP MMT-1715K 630G BLACK MG1,386
640G Insulin Pump MMT-1711K2,491
640G Insulin Pump MMT-1712K2,572
8CH Infinity DBS Lead Kit, 40cm, 0.5, B350
Accolade369
Activa270
AMS 800 Urinary Control System253
Animas Vibe1,090
Capsurefix Novus814
Coaguchek Xs System408
Dexcom G4 Platinum Continuous Glucose Monitoring System453
Dexcom G5 Mobile Continuous Glucose Monitoring System8,390
Dexcom G6 Continuous Glucose Monitoring System8,307
Endo GIA298
Endotak Reliance564
Essure364
Ingevity665
Intellis315
Liberty Select Cycler Assy Non-Valuated270
LifeVest WCD 4000 System698
Natura689
Ni405
Octrode Lead Kit, 60cm Length379
OmniPod Insulin Pump891
Paradigm Real-Time Revel Insulin Infusion Pump367
Paradigm REAL-Time REVEL Insulin Infusion Pump MMT-723LNAS268
Paradigm Real-Time Revel Insulin Infusion Pump Mmt-723nas272
Perclose Proglide 6f Suture Mediated Closure Smc System282
Pump MMT-1780KPK 670G Pathway Black MG3,232
Reservoir 3ML MMT-332A313
Reveal LINQ279
S-Icd System277
Spectrum Infusion Pump540
Sprint Quattro Secure S266
Style 68 Saline Filled Breast Implant456
SureScan382
T Slim G5 System1,640
t:slim G4 system436
t:slim X2 Insulin Pump319
t:slim X2 Insulin Pump with Basal-IQ Technology404
Teligen375
Tendril Sts291
V60 Ventilator262

Cite this page

Reported Reactions. October 2018: adverse event reports received by FDA. https://reportedreactions.com/month/2018-10/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of . Reports received through .

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The device counts come from the openFDA Device Adverse Event (MAUDE) bulk files, release of 23 Oct 2026. The files have the reports that FDA received through 30 Sep 2026. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

Can the count for October 2018 change?

Yes. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases. This page has the count of the openFDA release of 29 Oct 2026: 122,768 drug reports.

Does a month with many reports mean that something occurred in that month?

Not by itself. The date is the date on which FDA received the report, not the date of the event. FDA says:

Many factors can influence whether or not an event will be reported, such as the time a product has been marketed and publicity about an event.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

How does a person report an adverse event?

FDA runs MedWatch, a program that takes voluntary reports from health professionals, patients and consumers. The guide on how to report has the links.